09-14-2023
Washington, D.C., Sept. 14 , 2023 – Modavar Pharmaceuticals announced today that it has launched Telmisartan Tablets. The launch of the three strengths of Telmisartan (20mg, 40mg and 80mg in bottles of 30’s) adds to the growing line of products in the Modavar portfolio. The product is available immediately and is AB-rated to Boehringer Ingelheim’s Micardis®. Total market s
06-26-2023
Washington, D.C., June 26, 2023 – Modavar Pharmaceuticals announced today that it has launched Paroxetine ER Tablets. The launch of the three strengths of Paroxetine (12.5mg, 25mg and 37.5mg in bottles of 30’s) adds to the growing line of products in the Modavar portfolio. The product is available immediately and is AB-rated to Apotex’s Paxil® CR. Total market sales for this product a
05-16-2023
Washington, D.C., May 16 , 2023 – Modavar Pharmaceuticals announced today that it has launched Acyclovir Capsules. The launch of the 200mg strength of Acyclovir adds to the growing line of products in the Modavar portfolio. The product is available immediately and is AB-rated to Mylan’s Zovirax®. Total market sales for this product are approximately $2.8 million (IMS MAT